|
1
|
Toll-like receptors in inflammation, infection and cancer.
|
Int Immunopharmacol
|
2007
|
1.76
|
|
2
|
Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.
|
Cell Mol Immunol
|
2004
|
1.75
|
|
3
|
Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.
|
J Biol Chem
|
2005
|
1.39
|
|
4
|
Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor.
|
J Immunol
|
2004
|
1.35
|
|
5
|
Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose.
|
J Immunol
|
2004
|
1.22
|
|
6
|
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
|
J Natl Cancer Inst
|
2005
|
1.21
|
|
7
|
Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor.
|
J Immunol
|
2004
|
1.20
|
|
8
|
Toll-like receptors are key players in neurodegeneration.
|
Int Immunopharmacol
|
2011
|
0.95
|
|
9
|
TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways.
|
J Immunol
|
2004
|
0.95
|
|
10
|
Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand.
|
J Immunol
|
2007
|
0.92
|
|
11
|
Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.
|
Neurobiol Dis
|
2011
|
0.90
|
|
12
|
Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis.
|
FEBS J
|
2005
|
0.90
|
|
13
|
Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.
|
J Immunol
|
2009
|
0.88
|
|
14
|
Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity?
|
Cytokine Growth Factor Rev
|
2007
|
0.88
|
|
15
|
The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer.
|
Cell Mol Immunol
|
2005
|
0.84
|
|
16
|
Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy.
|
FASEB J
|
2012
|
0.82
|
|
17
|
Nordy, a synthetic lipoxygenase inhibitor, inhibits the expression of formylpeptide receptor and induces differentiation of malignant glioma cells.
|
Biochem Biophys Res Commun
|
2006
|
0.80
|
|
18
|
Silencing the formylpeptide receptor FPR by short-interfering RNA.
|
Mol Pharmacol
|
2004
|
0.79
|
|
19
|
The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes.
|
Cell Mol Immunol
|
2004
|
0.76
|
|
20
|
Manipulating chemoattractant and receptor genes.
|
In Vivo
|
2002
|
0.75
|
|
21
|
Interaction of bacterial toxin with leukocytes measured by flow cytometry.
|
Curr Microbiol
|
2002
|
0.75
|
|
22
|
The role of chemokine receptors in the promotion of viral infections.
|
Contrib Microbiol
|
2003
|
0.75
|
|
23
|
Toll-like receptors and diseases.
|
Int Immunopharmacol
|
2011
|
0.75
|
|
24
|
Determination of human sperm calcium uptake mediated by progesterone may be useful for evaluating unexplained sterility.
|
Fertil Steril
|
2004
|
0.75
|